A conspicuous new concept of pathogens living as the microbial societies in the human host
rather than free planktonic cells has raised considerable concerns among scientists and …

The current treatment options for Candida albicans biofilm-device related infections are very
scarce due to their intrinsic increased tolerance to antimycotics. The aim of this work was to …

In recent decades, fungal infections have incredibly increased with Candida genus as the
major cause of morbidity and mortality in hospitalized and immunocompromised patients …

Fungal pathogens, including Candida spp., Aspergillus spp. and dermatophytes, cause
more than a billion human infections every year. A large library of imidazole-and triazole …

Objectives The aims of this study were to develop new anti-biofilm drugs, examine their
activity against Candida albicans biofilm and investigate their structure–activity relationship …

The development of new antifungal agents that target biofilms is an urgent need. Natural
products, mainly from the plant kingdom, represent an invaluable source of these entities …

Candida albicans is the causative agent of fatal systemic candidiasis. Due to limitations of
antifungals, new drugs are needed. The anti-virulence effect of plant essential oils (EOs) …

Candida biofilms on various implanted medical devices and living tissues are serious
concern in several hospital-acquired infections. The study was conducted to employ a new …

Aspergillus nidulans, an endophytic fungus isolated from the medicinal plant Acacia nilotica
showed potent antifungal activity against oral pathogenic strains of Candida albicans …

The virulence factors of Candida albicans are germ tube and biofilm formation, adherence to
host tissues, and production of hydrolytic enzymes. This study investigated the effect of …